Clinical and Molecular Spectrum of Nonsyndromic Early‐Onset Osteoarthritis - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Arthritis & rheumatology Année : 2020

Clinical and Molecular Spectrum of Nonsyndromic Early‐Onset Osteoarthritis

David Geneviève
  • Fonction : Auteur
  • PersonId : 907874

Résumé

Objective. Osteoarthritis (OA) is the most common joint disease worldwide. The etiology of OA is varied, ranging from multifactorial to environmental to monogenic. In a condition called early-onset OA, OA occurs at an earlier age than is typical in the general population. To our knowledge, there have been no large-scale genetic studies of individuals with early-onset OA. The present study was undertaken to investigate causes of monogenic OA in individuals with nonsyndromic early-onset OA.Methods. The study probands were 45 patients with nonsyndromic early-onset OA who were referred to our skeletal disease center by skeletal dysplasia experts between 2013 and 2019. Criteria for early-onset OA included radiographic evidence, body mass index ≤30 kg/m 2 , age at onset ≤50 years, and involvement of ≥1 joint site. Molecular analysis was performed with a next-generation sequencing panel Results. We identified a genetic variant in 13 probands (29%); the affected gene was COL2A1 in 11, ACAN in 1, and SLC26A2 in 1. After familial segregation analysis, 20 additional individuals were identified. The mean ± SD age at onset of joint pain was 19.5 ± 3.9 years (95% confidence interval 3-47). Eighteen of 33 subjects (55%) with nonsyndromic early-onset OA and a genetic variant had had at least 1 joint replacement (mean ± SD age at first joint replacement 41 ± 4.2 years; mean number of joint replacements 2.6 per individual), and 21 (45%) of the joint replacement surgeries were performed when the patient was <45 years old. Of the 20 patients age >40 years, 17 (85%) had had at least 1 joint replacement.Conclusion. We confirmed that COL2A1 is the main monogenic cause of nonsyndromic early-onset OA. However, on the basis of genetic heterogeneity of early-onset OA, we recommend next-generation sequencing for all individuals who undergo joint replacement prior to the age of 45 years. Lifestyle recommendations for prevention should be implemented. ClinicalTrials.gov identifier: NCT04267510.
Fichier principal
Vignette du fichier
art.41387 (1).pdf (526.71 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03714570 , version 1 (05-07-2022)

Identifiants

Citer

Valentin Ruault, Kevin Yauy, Aurélie Fabre, Mélanie Fradin, Julien Van-Gils, et al.. Clinical and Molecular Spectrum of Nonsyndromic Early‐Onset Osteoarthritis. Arthritis & rheumatology, 2020, 72 (10), pp.1689 - 1693. ⟨10.1002/art.41387⟩. ⟨hal-03714570⟩
143 Consultations
225 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More